Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Infections | Nursing | Surgery | Urology | Journal

Back to Journal Articles

Leaving Balloon in Is Safe in Urinary Sphincter Revision

Last Updated: September 21, 2012.

 

Original pressure-regulating balloon can be left in place during artificial urinary sphincter revision

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Intentionally leaving the pressure-regulating balloon in place during a non-infected artificial urinary sphincter revision procedure is safe and is not associated with infection or complications, according to research published online Sept. 13 in The Journal of Sexual Medicine.

FRIDAY, Sept. 21 (HealthDay News) -- Intentionally leaving the pressure-regulating balloon in place during a non-infected artificial urinary sphincter (AUS) revision procedure is safe and is not associated with infection or complications, according to research published online Sept. 13 in The Journal of Sexual Medicine.

Tobias S. Köhler, M.D., M.P.H., of the Southern Illinois University School of Medicine in Springfield, and colleagues conducted a retrospective review to describe long-term outcomes in 35 patients with an artificial urinary sphincter (AUS) who underwent 36 AUS revisions. During the revisions, the original pressure-regulating balloon was left in place, while the defective cuff and pump were removed and replaced.

The researchers found that, after a mean follow-up of 14 months, 11 percent of patients in this revision series experienced a complication. However, no infections or complications occurred secondary to the retained pressure-regulating balloon.

"This series' data with short- to medium-term follow-up [indicate] that leaving the original fluid pressure-regulating balloon undisturbed during AUS revision in a non-infected setting safely avoids a potential counter incision and is not associated with intraoperative or postoperative complications," the authors write.

Several authors disclosed financial ties to the medical device industry.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Patient Preference Doesn't Affect Chemo in Advanced CRC Next: Central Centrifugal Cicatricial Alopecia Pathogenesis Studied

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.